Regenicin logo

RGIN Regenicin

Regenicin, Inc. is a biotechnology company, which specializing in the development of regenerative cell therapies to restore the health of damaged tissues and organs. It intends to develop and commercialize a potentially lifesaving technology by the introduction of tissue-engineered skin substitutes to restore the qualities of healthy human skin for use in the treatment of burns, chronic wounds and a variety of plastic surgery procedures. The company was founded on September 6, 2007 and is headquartered in Little Falls, NJ.

Industrials Conglomerates SIC: Unknown CIK: 1412659 Auditor raised Going Concern issues

Login to follow RGIN

Transaction DateRecipientSharesTypePriceValue
Jodie Insights Rating